glp 1 for inflammatory arthritis GLP-1 Medications and Rheumatoid Arthritis: What the 2025 Research Actually Shows Anti-Inflammatory Effects of GLP-1 Receptor

The agency flagged three adverse events in its FAERS database tied to compounded injectable BPC-157, including a case in which a patient developed diffuse hyperpigmentation and gingival darkening after using a blended BPC-157/TB-500 product labeled "research purposes only." The safety concern most specific to BPC-157 is its mechanism of action

others will be seeking comprehensive support

The prevalence of T2DM is predicted to rise by 46% globally by 2045, suggesting that this issue becomes even more ominous as time progresses

Eli Lilly has hit $1 trillion in market value, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse